NCT02522845

Brief Summary

This study will be looking at the effect of compression therapy in patients having endovenous treatment for truncal incompetence of their varicose veins using either radiofrequency ablation (RFA) or endovenous laser therapy (EVLT). Patients will be randomised to either the compression group (group A) or the no compression group (group B). The pain scores, compliance, quality of life scores, occlusion rate at 6 months as well as the cost effectiveness of each intervention will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
204

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 13, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 27, 2020

Completed
Last Updated

September 6, 2022

Status Verified

August 1, 2022

Enrollment Period

4 years

First QC Date

August 4, 2015

Results QC Date

June 4, 2020

Last Update Submit

August 4, 2022

Conditions

Keywords

Varicose VeinsCompression StockingsLaser AblationCatheter Ablation, Radiofrequency

Outcome Measures

Primary Outcomes (1)

  • Patient's Post-procedure Pain Score Using a Visual Analogue Scale (VAS)

    Patients indicating level of pain they were having using a VAS scale. The scale is a 100mm line drawn going from 0-100 (0=no pain; 100=worse pain)

    Up to 10 days

Secondary Outcomes (9)

  • The Generic Quality of Life Score Using the EQ-5D Score

    Up to 6 months

  • The Specific Quality of Life Score Using the Aberdeen Varicose Vein Questionnaire (AVVQ) Score

    Up to 6 months

  • The Specific Quality of Life Score Using the CIVIQ Score

    Up to 6 months

  • The Clinical Score Using the Venous Clinical Severity Score

    Up to 6 months

  • The Degree of Bruising and Phlebitis

    Up to 6 months

  • +4 more secondary outcomes

Study Arms (2)

Compression

ACTIVE COMPARATOR

Patients randomised to this group will be asked to wear Class II compression stockings for 1 week

Device: Class II Compression Stockings (no specific device used)

No Compression

NO INTERVENTION

Patients randomised to this group will not be provided with any compression

Interventions

This study will be looking at the effect of compression therapy in patients having endothermal treatment for truncal incompetence of their varicose veins

Compression

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 18 years of age
  • Symptomatic GSV or SSV vein reflux \> 0.5 seconds on colour Duplex

You may not qualify if:

  • Current DVT
  • Recurrent varicose veins
  • Patients requiring adjuvant treatment of varicose veins
  • Arterial disease (ABPI\<0.8)
  • Vein diameter \< 3mm
  • Patient who are unwilling to participate
  • Inability or unwillingness to complete questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charing Cross Hospital, Imperial College London

London, W6 8RF, United Kingdom

Location

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Limitations and Caveats

1. Power of the study was decreased from 90% to 80%. 2. The use of analgesia was not recorded so that it is unclear whether the pain score observed was with or without analgesia.

Results Point of Contact

Title
Mr Roshan Bootun
Organization
Imperial College London

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2015

First Posted

August 13, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

September 6, 2022

Results First Posted

July 27, 2020

Record last verified: 2022-08

Locations